Article Details

Myeloma Drug ORIC-533: Early Trial Update - HealthTree for Multiple Myeloma

Retrieved on: 2024-04-26 18:33:04

Tags for this article:

Click the tags to see associated articles and topics

Myeloma Drug ORIC-533: Early Trial Update - HealthTree for Multiple Myeloma. View article details on hiswai:

Excerpt

How ORIC-533 Works: Targeting the Adenosine Pathway. This drug in development is a small molecule (compared to, e.g., monoclonal antibody drugs such ...

Article found on: healthtree.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo